Crestwood Advisors Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,715
Closed -$281K 794
2025
Q4
$281K Sell
1,715
-741
-30% -$116K ﹤0.01% 543
2025
Q3
$328K Sell
2,456
-432
-15% -$52.5K 0.01% 450
2025
Q2
$359K Sell
2,888
-759
-21% -$96.6K 0.01% 403
2025
Q1
$464K Buy
+3,647
New +$561K 0.01% 351

Other funds holding RGEN

Crestwood Advisors Group's RGEN Position: Q1 2026 in Review

Crestwood Advisors Group sold out of Repligen (RGEN) in Q1 2026, closing a stake of 1,715 shares — an estimated $281K sold.

Crestwood Advisors Group first reported a position in RGEN in Q1 2025 and held it in 4 quarters. The position peaked at $464K in Q1 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Crestwood Advisors Group reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Crestwood Advisors Group sold 1,715 Repligen shares in Q1 2026, an estimated $281K.
  • Crestwood Advisors Group first reported a position in Repligen in Q1 2025 and held it in 4 quarters.
  • Crestwood Advisors Group's Repligen position peaked at $464K in Q1 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Crestwood Advisors Group's 13F filing for Q1 2026, filed 5 May 2026.